Table 2. Cancer types and corresponding measures of burden and survival in the United States.
| Cancer | Incident Casesa | Annual Deathsa | Five-year Survival (%), 1999–2006 | Absolute Change in Survival vs 1990–1992 | Relative Change in Survival vs 1990–1992, % | Five-year Mortality Estimate |
|---|---|---|---|---|---|---|
| Liver and intra-hepatic bile duct |
24,120 |
18,910 |
14.4 |
8.5 |
144.1 |
20,647 |
| Esophagus |
16,440 |
14,500 |
18.9 |
6.3 |
50.0 |
13,333 |
| Non-Hodgkin lymphoma |
65,540 |
20,210 |
69.1 |
17.3 |
33.4 |
20,252 |
| Myeloma |
20,180 |
10,650 |
38.5 |
8.0 |
26.2 |
12,411 |
| Pancreas |
43,140 |
36,800 |
5.7 |
1.1 |
23.9 |
40,681 |
| Stomach |
21,000 |
10,570 |
26.7 |
5.1 |
23.6 |
15,393 |
| Leukemia |
43,050 |
21,840 |
55.3 |
8.5 |
18.2 |
19,243 |
| Lung and bronchus |
222,520 |
157,300 |
16.4 |
2.4 |
17.1 |
186,027 |
| Kidney and renal pelvis |
58,240 |
13,040 |
69.6 |
8.2 |
13.4 |
17,705 |
| Brain and other nervous system |
22,020 |
13,140 |
36.3 |
4.1 |
12.7 |
14,027 |
| Oral cavity and pharynx |
36,540 |
7,880 |
62.7 |
6.7 |
12.0 |
13,629 |
| Ovary |
21,880 |
13,880 |
45.3 |
2.7 |
6.3 |
11,968 |
| Prostate |
217,730 |
32,050 |
99.6 |
5.9 |
6.3 |
871 |
| Breastb |
209,060 |
40,230 |
89.9 |
4.5 |
5.3 |
21,115 |
| |
|
|
|
|
|
|
| Hodgkin Lymphoma |
8,490 |
1,320 |
86.8 |
4.0 |
4.8 |
1,121 |
| Colon |
102,900 |
51,370 |
65.8 |
2.8 |
4.4 |
35,192 |
| Melanoma |
68,130 |
8,700 |
93.0 |
3.5 |
3.9 |
4,769 |
| Thyroid |
44,670 |
1,690 |
97.4 |
2.4 |
2.5 |
1,161 |
| Cervix |
12,200 |
4,210 |
71.1 |
0.5 |
0.7 |
3,526 |
| Bladder |
70,530 |
14,680 |
81.1 |
0.5 |
0.6 |
13,330 |
| Testis |
8,480 |
350 |
96.3 |
0.5 |
0.5 |
314 |
| Larynx | 12,720 | 3,600 | 62.9 | -3.4 | -5.1 | 4,719 |
Survival rate data from National Cancer Institute Surveillance Epidemiology and End Results (SEER) database. Data accessed March 4, 2011 from http://seer.cancer.gov/; time frames pre-defined by SEER. Incidence and annual mortality data obtained from reference 1. Five-year mortality estimates from authors’ calculations—see Methods. aValues from 2010. bSurvival rate data only represent females while rest of data reflect both sexes.